W. Rhomberg

750 total citations
49 papers, 527 citations indexed

About

W. Rhomberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, W. Rhomberg has authored 49 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in W. Rhomberg's work include Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (7 papers) and Cancer Diagnosis and Treatment (6 papers). W. Rhomberg is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Vascular Tumors and Angiosarcomas (7 papers) and Cancer Diagnosis and Treatment (6 papers). W. Rhomberg collaborates with scholars based in Austria, United States and Germany. W. Rhomberg's co-authors include James F. Holland, John Milton Mishler, Donald J. Higby, R. W. Nicora, Hans-Joerg Senn, G Breitfellner, William P. Peters, Tarit K. Banerjee, E. Cohen and Hans‐Joachim Schmoll and has published in prestigious journals such as New England Journal of Medicine, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

W. Rhomberg

46 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Rhomberg Austria 13 239 169 146 104 74 49 527
S. Osanto Netherlands 12 162 0.7× 249 1.5× 216 1.5× 45 0.4× 123 1.7× 22 786
Fatih Selçukbırıcık Türkiye 16 246 1.0× 342 2.0× 247 1.7× 68 0.7× 37 0.5× 93 761
Kennedy Bj United States 12 115 0.5× 129 0.8× 274 1.9× 44 0.4× 74 1.0× 36 563
Jennifer Herring United States 11 347 1.5× 175 1.0× 137 0.9× 45 0.4× 153 2.1× 21 788
R. Finney United Kingdom 14 80 0.3× 144 0.9× 127 0.9× 53 0.5× 215 2.9× 35 600
Bernard L. Zidar United States 15 170 0.7× 345 2.0× 58 0.4× 51 0.5× 80 1.1× 22 632
Charles E. Alpers United States 14 82 0.3× 114 0.7× 85 0.6× 190 1.8× 53 0.7× 17 812
Akinari Sekine Japan 12 112 0.5× 154 0.9× 110 0.8× 95 0.9× 41 0.6× 113 667
Ann Hanly Ireland 17 535 2.2× 145 0.9× 496 3.4× 63 0.6× 57 0.8× 43 922
Varun Mittal India 13 175 0.7× 186 1.1× 115 0.8× 76 0.7× 65 0.9× 47 655

Countries citing papers authored by W. Rhomberg

Since Specialization
Citations

This map shows the geographic impact of W. Rhomberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Rhomberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Rhomberg more than expected).

Fields of papers citing papers by W. Rhomberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Rhomberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Rhomberg. The network helps show where W. Rhomberg may publish in the future.

Co-authorship network of co-authors of W. Rhomberg

This figure shows the co-authorship network connecting the top 25 collaborators of W. Rhomberg. A scholar is included among the top collaborators of W. Rhomberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Rhomberg. W. Rhomberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhomberg, W., et al.. (2014). Long-term survival in patients with incurable breast cancer. An analysis of 93 cases.. PubMed. 34(10). 5637–42. 3 indexed citations
2.
Rhomberg, W., et al.. (2008). Treatment of Vascular Soft Tissue Sarcomas With Razoxane, Vindesine, and Radiation. International Journal of Radiation Oncology*Biology*Physics. 74(1). 187–191. 7 indexed citations
3.
Rhomberg, W., et al.. (2007). Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas. Clinical & Experimental Metastasis. 25(1). 75–80. 3 indexed citations
4.
Rhomberg, W., et al.. (2007). Irradiation with and without Razoxane in the Treatment of Incompletely Resected or Inoperable Recurrent Rectal Cancer. Strahlentherapie und Onkologie. 183(7). 380–384. 4 indexed citations
5.
Mayer, Ramona, Franz Quehenberger, J. Hammer, et al.. (2007). Austrian Breast Cancer Patterns-of-Care Studies PCS93 and PCS01 versus PCS85 to Identify Changes in National Practice. Strahlentherapie und Onkologie. 183(4). 170–176. 4 indexed citations
6.
Rhomberg, W., et al.. (2005). Combined Razoxane and Radiotherapy for Melanoma Brain Metastases. A Retrospective Analysis. Journal of Neuro-Oncology. 74(3). 295–299. 3 indexed citations
7.
Rhomberg, W. & Felix Offner. (2005). Porphyrie und Radiotherapie: doch eine Risikokonstellation?. Strahlentherapie und Onkologie. 181(6). 401–404. 5 indexed citations
8.
Mayer, Ramona, Franz Quehenberger, J. Hammer, et al.. (2004). Patterns of care in radiotherapy of breast cancer in Austria 1985: data acquisition and comparison with data of US-PCS 1983. Radiotherapy and Oncology. 72(1). 45–51. 3 indexed citations
9.
Rhomberg, W., et al.. (2004). Treatment options for malignant hemangioendotheliomas of the thyroid. International Journal of Radiation Oncology*Biology*Physics. 60(2). 401–405. 8 indexed citations
10.
Rhomberg, W., et al.. (2003). A Small Prospective Study of Chordomas Treated with Radiotherapy and Razoxane. Strahlentherapie und Onkologie. 179(4). 249–253. 19 indexed citations
11.
Rhomberg, W., et al.. (2000). Aggressive Angiomyxoma: Irradiation for Recurrent Disease. Strahlentherapie und Onkologie. 176(7). 324–326. 25 indexed citations
12.
Rhomberg, W.. (1998). Exposure to polymeric materials in vascular soft-tissue sarcomas. International Archives of Occupational and Environmental Health. 71(5). 343–347. 5 indexed citations
13.
Rhomberg, W., et al.. (1996). Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: Final results of a randomized study. International Journal of Radiation Oncology*Biology*Physics. 36(5). 1077–1084. 33 indexed citations
14.
Rhomberg, W., et al.. (1995). High frequency of metalworkers among patients with seminomatous tumors of the testis: A case‐control study. American Journal of Industrial Medicine. 28(1). 79–87. 26 indexed citations
15.
Rhomberg, W., et al.. (1994). Inoperable recurrent rectal cancer: Results of a prospective trial with radiation therapy and razoxane. International Journal of Radiation Oncology*Biology*Physics. 30(2). 419–425. 22 indexed citations
16.
Rhomberg, W., et al.. (1990). Long-term application of vindesine: toxicity and tolerance. Journal of Cancer Research and Clinical Oncology. 116(6). 651–653. 4 indexed citations
17.
Rhomberg, W., et al.. (1988). Aggressive fibromatosis a rare cause for lumbar bulging. Archives of Orthopaedic and Trauma Surgery. 107(6). 388–390. 6 indexed citations
18.
Rhomberg, W., et al.. (1978). [Clinical experiences with radiotherapy and ICRF 159 in sarcomas].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 75. 110–4. 1 indexed citations
19.
Rhomberg, W., K. Hellmann, & R. D. H. Ryall. (1974). Strahlentherapie und ICRF 159 (NSC 129943) in der Behandlung inoperabler Weichteilsarkome. DMW - Deutsche Medizinische Wochenschrift. 99(48). 2438–2442. 5 indexed citations
20.
Rhomberg, W.. (1968). [Contribution to the research of the so-called rudimentary paraproteinemias].. PubMed. 98(15). 568–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Osanto Breakdown of academic impact, for papers by Fatih Selçukbırıcık Breakdown of academic impact, for papers by Kennedy Bj Breakdown of academic impact, for papers by Jennifer Herring Breakdown of academic impact, for papers by R. Finney Breakdown of academic impact, for papers by Bernard L. Zidar Breakdown of academic impact, for papers by Charles E. Alpers Breakdown of academic impact, for papers by Akinari Sekine Breakdown of academic impact, for papers by Ann Hanly Breakdown of academic impact, for papers by Varun Mittal
Rankless by CCL
2026